HOUSTON, July 8, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced various community-driven accolades the Company and its hospitals received in the second quarter of 2025.Nutex Health hospitals have historically served as the safety net ...

Company Overview - Nutex Health Inc. is a physician-led, integrated healthcare delivery system with 24 micro hospitals and hospital outpatient departments (HOPDs) across 11 states [1][4] - The company operates two divisions: a Hospital Division and a Population Health Management Division [4][5] Recent Developments - Nutex Health has filed a supplement to its proxy statement on June 27, 2025, encouraging shareholders to review the new information [1] - The company's Annual Meeting of common stockholders is scheduled for July 14, 2025, at 10:00 am Central Time [2] Shareholder Information - Stockholders can access the definitive proxy statement dated June 2, 2025, and the Form 10-K online or request a free paper or email copy [2][3] - Instructions for requesting materials include visiting a specific website, calling a designated number, or sending an email with a control number [3]

TOTAL REVENUE OF $211.8 MILLION VERSUS $67.5 MILLION IN Q1 2024, AN INCREASE OF 213.8% NET INCOME ATTRIBUTABLE TO NUTEX HEALTH INC. OF $14.6 MILLION VERSUS NET LOSS OF $0.4 MILLION IN Q1 2024 DILUTED EPS OF $2.56 PER SHARE VERSUS $(0.08) PER SHARE IN Q1 2024 EBITDA OF $43.1 MILLION VERSUS $7.1 MILLION IN EBITDA IN Q1 2024, AN INCREASE OF 507.0% ADJUSTED EBITDA OF $72.8 MILLION VERSUS $(0.4) MILLION IN Q1 2024 NET CASH FROM OPERATING ACTIVITIES OF $51.0 MILLION COMPANY BELIEVES ITS ARBITRATION EFFORTS THROU ...

Core Insights - Nutex Health Inc. reported significant financial growth for the fiscal year 2024, with total revenue reaching $479.9 million, a 93.8% increase from $247.6 million in 2023 [5] - The company achieved a net income of $52.2 million compared to a net loss of $45.8 million in the previous year, marking a substantial turnaround [5] - The arbitration process initiated in July 2024 contributed approximately $169.7 million in additional revenue, accounting for 73.1% of the overall revenue increase [5][8] Financial Performance - Total revenue for the year ended December 31, 2024, was $479.9 million, up from $247.6 million in 2023, reflecting a growth of $232.3 million [5] - Net income for the year was $52.2 million, a significant improvement from the net loss of $45.8 million in 2023 [5] - EBITDA for the year was $98.4 million, compared to a negative EBITDA of $(22.5) million in 2023 [5] - Adjusted EBITDA reached $123.7 million, a remarkable increase of 1,045.4% from $10.8 million in 2023 [5] Quarterly Highlights - For the fourth quarter of 2024, total revenue was $257.6 million, a 269.6% increase from $69.7 million in the same quarter of 2023 [5] - Net income for the fourth quarter was $61.7 million, compared to a net loss of $31.7 million in the fourth quarter of 2023 [5] - Total visits at the Hospital Division increased by 16.9% year-over-year, with mature hospitals seeing a 6.5% increase in visits [5][7] Operational Metrics - The company operated 24 micro hospitals and outpatient departments across 11 states, focusing on integrated healthcare delivery [2][24] - The arbitration initiative has led to higher reimbursement amounts per visit, aligning more closely with fair market rates [8] - The company plans to continue optimizing operations and maintaining a lean cost structure to support sustained growth in 2025 [7]